ROCHE Archives

The Future of Diabetes Care: Key Innovations in the Continuous Glucose Monitoring

21/10/2024by EOS Intelligence

Continuous glucose monitors (CGM) represent a disruptive innovation that has transformed the diabetes management landscape. In recent years, the CGM market has seen remarkable growth, becoming an integral part of...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm

30/05/2024by EOS Intelligence

Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...

Anti-Obesity Drugs – Pharma Companies Race to Grab a Bite of the Pie

16/04/2024by EOS Intelligence

For many years, bariatric surgery has been the go-to option for people struggling with obesity and obesity-induced conditions. However, for the last couple of years, another easier option has become...

Diagnostics Gain Spotlight amid Coronavirus Outbreak

22/02/2022by EOS Intelligence

It took 60 days for global COVID-19 infections to reach 100,000, but this figure doubled in the following 12-14 days, and the addition of next 100,000 cases took only 3...

Will Pharma Tweet Louder? 6 Rules of Doing it Right on Social Media

23/05/2013by EOS Intelligence

Initially considered to be exclusively a tool for common people to connect with friends and share their private pictures, social media platforms have now gained the status of a potent...

Who We Are

Connect With Us

Work With EOS